Pomdoctor Limited (POM)

NASDAQ: POM · Real-Time Price · USD
0.1213
+0.0035 (2.97%)
At close: May 19, 2026, 4:00 PM EDT
0.1104
-0.0109 (-8.99%)
After-hours: May 19, 2026, 7:16 PM EDT
Market Cap14.37M
Revenue (ttm)57.18M +16.7%
Net Income-30.39M
EPS-0.52
Shares Out 118.44M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume732,170
Open0.1143
Previous Close0.1178
Day's Range0.1143 - 0.1289
52-Week Range0.0649 - 6.4300
Betan/a
Analystsn/a
Price Targetn/a
Earnings DateMay 14, 2026

About POM

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company’s business primarily consists of internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other he... [Read more]

Sector Healthcare
IPO Date Oct 8, 2025
Employees 156
Stock Exchange NASDAQ
Ticker Symbol POM
Full Company Profile

Financial Performance

In 2025, Pomdoctor's revenue was 399.91 million, an increase of 16.74% compared to the previous year's 342.56 million. Losses were -212.58 million, 48.3% more than in 2024.

Financial numbers in CNY Financial Statements

News

POMDOCTOR LIMITED Announces Fiscal Year 2025 Financial Results

GUANGZHOU, China, May 14, 2026 /PRNewswire/ -- Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced...

5 days ago - PRNewsWire

POMDOCTOR LIMITED Announces Strategic Upgrade, Focusing on "AI + Medical-Grade Smart Wearables" to Build a New Ecosystem for Full-Cycle Chronic Disease Management

GUANGZHOU, China, March 13, 2026 /PRNewswire/ -- Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announc...

2 months ago - PRNewsWire

POMDOCTOR LIMITED Expands Platform Integration With Online Medical Insurance Coverage Across Major Chinese Cities

GUANGZHOU, China, Feb. 4, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced...

3 months ago - PRNewsWire

PomDoctor receives noncompliance notification from Nasdaq

PomDoctor (POM) announced that it has received a written notification from the staff of Nasdaq dated January 29, indicating that for the last 33 consecutive business days, the closing bid…

3 months ago - TheFly

POMDOCTOR LIMITED Announces Receipt of Nasdaq Notice

GUANGZHOU, China, Feb. 2, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced...

3 months ago - PRNewsWire

POMDOCTOR LIMITED Drive Internet Hospital Growth Through Strengthened Strategic Partnerships With Pharmaceutical Companies

GUANGZHOU, China, Jan. 16, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announce...

4 months ago - PRNewsWire

POMDOCTOR LIMITED Announces First Half of Fiscal 2025 Unaudited Financial Results

GUANGZHOU, China , Dec. 3, 2025 /PRNewswire/ -- Pomdoctor Limited ("Pomdoctor" or the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announce...

5 months ago - PRNewsWire

Citi Appointed as Depositary Bank for POMDOCTOR LIMITED's ADR Program

NEW YORK--(BUSINESS WIRE)--Citi Issuer Services, acting through Citibank, N.A., has been appointed by POMDOCTOR LIMITED (POM), a Chinese online medical services platform, as Depositary Bank for its Am...

7 months ago - Business Wire

POMDOCTOR LIMITED Announces Full Exercise and Closing of Underwriter's Over-Allotment Option

GUANGZHOU, China , Oct. 10, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (Nasdaq: POM) (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announc...

7 months ago - PRNewsWire

POMDOCTOR LIMITED Announces Closing of Initial Public Offering

GUANGZHOU, China , Oct. 9, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (Nasdaq: POM) (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announce...

7 months ago - PRNewsWire

PomDoctor 5M share IPO priced at $4.00

Joseph Stone Capital, LLC is acting as sole book running manager for the offering. The deal priced at low end of $4.00-$6.00 target range.

7 months ago - TheFly

PomDoctor opens at $4.50, IPO priced at $4.00 per share

PomDoctor (POM), an online medical services platform for chronic diseases in China, priced 5M American Depositary Shares at $4.00 per ADS. Joseph Stone Capital is acting as sole book running…

7 months ago - TheFly

POMDOCTOR LIMITED Announces Pricing of Initial Public Offering

GUANGZHOU, China , Oct. 8, 2025 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company" or "POMDOCTOR"), a leading online medical services platform for chronic diseases in China, today announced the pricing ...

7 months ago - PRNewsWire

Chinese online medical platform PomDoctor files for a $15 million US IPO

PomDoctor, an online platform in China offering chronic disease management services, filed on Thursday with the SEC to raise up to $15 million in an initial public offering.

1 year ago - Renaissance Capital

Pomdoctor IPO Registration Document (F-1)

Pomdoctor has filed to go public with an IPO on the NASDAQ.

1 year ago - SEC